Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637917 · ClinicalTrials.gov registry record
Pulse Oximetry Performance Comparison in Newborns
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 120
- Enrollment target
NCT06637917 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 120 participants.
The verdict
NCT06637917 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The overall purpose is to directly compare pulse rate (PR) acquisition and oxygen saturation performance between two pulse oximeters (PO) in newborns.
Interventions
- DEVICE OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System
- DEVICE LNCS® NEO SpO2 Sensor with RAD-97™ Pulse CO-Oximeter
- DEVICE 1041PTS (or similar) Kendall™ Neonatal Electrodes with IntelliVue MP5 Portable Patient Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-09-10 |
| Est. Completion | 2025-09-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06637917
The ClinicalTrials.gov registry entry for NCT06637917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System is the first listed.
NCT06637917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06637917 about?
NCT06637917 is a clinical study titled "Pulse Oximetry Performance Comparison in Newborns". The overall purpose is to directly compare pulse rate (PR) acquisition and oxygen saturation performance between two pulse oximeters (PO) in newborns.
What is the current status of trial NCT06637917?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2024-09-10. Estimated completion is 2025-09-18.
What interventions are being tested in trial NCT06637917?
The interventions under investigation include: OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System (DEVICE), LNCS® NEO SpO2 Sensor with RAD-97™ Pulse CO-Oximeter (DEVICE), 1041PTS (or similar) Kendall™ Neonatal Electrodes with IntelliVue MP5 Portable Patient Monitor (DEVICE).
Who is sponsoring clinical trial NCT06637917?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.